Capra Biosciences, Inc. — Form D
Capra Biosciences, Inc. of MANASSAS, VA, a company, filed a Form D exempt-offering notice with the SEC on 2024-10-01. The offering totals $1.5M, of which $500K was reported sold. Industry: Other Technology.
Offering
- Filed: 2024-10-01
- Form: D
- Accession: 0001902373-24-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $1.5M
- Amount sold: $500K
- Remaining: $1.0M
- Investors: 1
- Date of first sale: 2024-09-16
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-525535
Issuer
- Name: Capra Biosciences, Inc.
- CIK: 0001902373
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 11100 ENDEAVOR CT UNIT 149, MANASSAS, VA, 20109
- Phone: 202-709-4184
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Douglas Cameron | Director | Manassas, VA |
| Danielle Joseph | Director | Manassas, VA |
| Andrew Magyar | Director | Manassas, VA |
| Elizabeth Onderko | Director | Manassas, VA |
| Pae Wu | Director | Manassas, VA |
| Andrew Magyar | Executive Officer | Manassas, VA |
| Elizabeth Onderko | Executive Officer | Manassas, VA |
| Elizabeth Onderko | Promoter | Manassas, VA |
| Andrew Magyar | Promoter | Manassas, VA |
Other filings by this issuer (2)
More